Literature DB >> 16815962

Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.

Junko Sugatani1, Tadashi Wada, Makoto Osabe, Kasumi Yamakawa, Kouichi Yoshinari, Masao Miwa.   

Abstract

Inulin enzymatically synthesized from sucrose is a dietary component that completely escapes glucide digestion. Supplementing inulin to a high-fat and high-sucrose diet (HF) ameliorated hypertriglycemia and hepatic steatosis in 8-week-fed rats by suppressing elevated levels of serum triacylglycerols, fatty acids, and glucose, and the accumulation of hepatic triacylglycerols and fatty acids. Inulin intake prevented phenobarbital (PB)- and dexamethasone-induced liver injuries in the HF group. No significant alteration in the baseline expression of CYP2B, CYP2C11, CYP3A, and NADPH-cytochrome P450 (P450) reductase mRNAs and proteins was found. In contrast, baseline and PB-treated expressions of CYP2E1 mRNA were reduced in HF-fed rats. The induction of P450s in response to PB was affected by the nutritional status of the rats; mRNA levels of CYP2B1 and CYP3A1 after PB treatment, as assessed by quantitative real-time polymerase chain reaction analysis were reduced in the inulin-supplemented HF (HF+I) group, compared with those in the HF group. Western blot analysis detected the corresponding changes of CYP2B and CYP3A proteins. These alterations were correlated with changes in hepatic thiobarbituric acid-reactive substances. Furthermore, no significant difference in the expression of nuclear receptors constitutive androstane receptor, pregnane X receptor, and retinoid X receptor alpha and coactivator peroxisome proliferator-activated receptor-gamma coactivator 1alpha proteins was found in the hepatic nucleus between the HF and HF+I groups, but the expression of hepatocyte nuclear factor alpha (HNF4alpha) protein was significantly reduced in the HF+I group. Taken together, these results indicate that inulin intake ameliorates PB-induced liver injury, associated with a decline in lipid accumulation and PB-induced expression of CYP2B and CYP3A, which may be related by a reduction in the nuclear expression of HNF4alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815962     DOI: 10.1124/dmd.106.010645

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  16 in total

Review 1.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

Review 2.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

3.  Prebiotic inulin consumption reduces dioxin-like PCB 126-mediated hepatotoxicity and gut dysbiosis in hyperlipidemic Ldlr deficient mice.

Authors:  Jessie B Hoffman; Michael C Petriello; Andrew J Morris; M Abdul Mottaleb; Yipeng Sui; Changcheng Zhou; Pan Deng; Chunyan Wang; Bernhard Hennig
Journal:  Environ Pollut       Date:  2020-02-20       Impact factor: 8.071

Review 4.  The Gordian Knot of dysbiosis, obesity and NAFLD.

Authors:  Wajahat Z Mehal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

5.  Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet.

Authors:  Junko Sugatani; Makoto Osabe; Tadashi Wada; Kasumi Yamakawa; Yasuhiro Yamazaki; Tadanobu Takahashi; Akira Ikari; Masao Miwa
Journal:  Eur J Nutr       Date:  2008-06-16       Impact factor: 5.614

6.  Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease.

Authors:  Banrida Wahlang; Ming Song; Juliane I Beier; K Cameron Falkner; Laila Al-Eryani; Heather B Clair; Russell A Prough; Tanasa S Osborne; David E Malarkey; J Christopher States; Matthew C Cave
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-03       Impact factor: 4.219

Review 7.  The interplay between fiber and the intestinal microbiome in the inflammatory response.

Authors:  Shiu-Ming Kuo
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

8.  Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug-metabolizing enzymes in rats fed a high-fat and high-sucrose diet.

Authors:  Junko Sugatani; Satoshi Sadamitsu; Tadashi Wada; Yasuhiro Yamazaki; Akira Ikari; Masao Miwa
Journal:  Nutr Metab (Lond)       Date:  2012-03-27       Impact factor: 4.169

Review 9.  The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).

Authors:  Zahra Safari; Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.207

10.  Focus on therapeutic strategies of nonalcoholic Fatty liver disease.

Authors:  Marilena Durazzo; Paola Belci; Alessandro Collo; Enrica Grisoglio; Simona Bo
Journal:  Int J Hepatol       Date:  2012-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.